Lifshitz & Miller Law Firm Announces Investigation of Ambac Financial Group, Inc., CBL & Associates Properties Inc., Emergent BioSolutions, Inc., Insmed Incorporated, K12 Inc., Lipocine, Inc.,

Emergent BioSolutions, Inc. (EBS)

Lifshitz & Miller  announces investigation into possible breaches of fiduciary duties by the board of EBS specifically relating to future lucrative contract renewals and demand from the U.S. government for its anthrax vaccine BioThrax.

For more information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at info@jlclasslaw.com.

Insmed Incorporated (INSM)

Lifshitz & Miller  announces investigation into possible breaches of fiduciary duties by the board of INSM.  Specifically, whether Arikayce's approval by the EMA for the treatment of NTM lung disease and subsequent commercialization in Europe were less likely and/or imminent than Insmed had led investors to believe.

For more information about our investigation, please contact Joshua M. Lifshitz, Esq. by telephone at (516) 493-9780 or by sending an e-mail including your contact information to: info@jlclasslaw.com.

K12 Inc. (LRN)

Lifshitz & Miller  announces investigation into possible breaches of fiduciary duties by the board of LRN.  Specifically, whether LRN was publishing misleading advertisements about students' academic progress, parent satisfaction, their graduates' eligibility for University of California and California State University admission, class sizes, the individualized and flexible nature of K12's instruction, hidden costs, and the quality of the materials provided to students; and LRN submitted inflated student attendance numbers to the California Department of Education in order to collect additional funding.

For more information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at info@jlclasslaw.com.

Lipocine, Inc. (LPCN)

Lifshitz & Miller  announces investigation into possible breaches of fiduciary duties by the board of LPCN.  Specifically, whether LPCN concealed from the investing public that: LPCN's NDA for TLANDOTM ("LPCN 1021") contained deficiencies.

For more information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at info@jlclasslaw.com.

Stericycle, Inc, (SRCL)

Lifshitz & Miller  announces investigation into possible breaches of fiduciary duties by the board of SRCL.  Specifically, whether the Company improperly recognized the timing of certain legal expenses in 2015 and missed analysts' earnings estimates.

For more information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at info@jlclasslaw.com.

© 2016 Lifshitz & Miller.  The law firm responsible for this advertisement is Lifshitz & Miller, 821 Franklin Avenue, Suite 209, Garden City, New York 11530, Tel: (516)493-9780.  Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact:
Joshua M. Lifshitz, Esq.
Lifshitz & Miller
Phone:  516-493-9780 
Facsimile: 516-280-7376
Email: info@jlclasslaw.com

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/lifshitz--miller-law-firm-announces-investigation-of-ambac-financial-group-inc-cbl--associates-properties-inc-emergent-biosolutions-inc-insmed-incorporated-k12-inc-lipocine-inc-and-stericycle-inc-300307528.html

SOURCE Lifshitz & Miller Law Firm